DTP Vaccines Global Market Report 2023

Description

“DTP Vaccines Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dtp vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dtp vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The dtp vaccines market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product Type: DTaP; TD; Tdap

2) By Disease: Diphtheria; Pertussis; Tetanus.

3) By End User: Hospitals; Clinics; Vaccination Centers

Companies Mentioned: Merck & Co; Sanofi; GSK; Lanzhou Institute of Biological Products; Novartis AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the DTP vaccines market are: Merck & Co, Sanofi, GSK, Lanzhou Institute of Biological Products, Novartis AG, Pfizer Inc, Johnson & Johnson, Seqirus, AJ Vaccines, and Bionet-Asia.

The global DTP vaccines market will grow from $6.02 billion in 2022 to $6.39 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The DTP vaccines market is expected to grow from $7.79 billion in 2027 at a CAGR of 5.1%.

The DTP vaccines market consists of sales of daptacel, infanrix, kinrix, pediarix, pentacel, quadracel, and vaxelis vaccines. Values in this market are: 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

DTP vaccines refer to a combination vaccine given intramuscularly to protect children under the age of 7 from the illnesses diphtheria, tetanus, and whooping cough. It aids kids in acquiring resistance to the three bacterial illnesses diphtheria, tetanus, and pertussis, which are all fatal.

The main types of products in DTP vaccines are DTaP, TD, and Tdap. Diphtheria, tetanus and whooping cough (DTaP) vaccine help children under the age of seven build protection against three lethal bacteria-borne diseases: diphtheria, tetanus, and whooping cough (pertussis). The different types of diseases include diphtheria, pertussis, and tetanus and involve various sectors such as hospitals, clinics, and vaccination centers.

Governments across the world are encouraging the R&D of DTP vaccines to disallow the spread of the diseases. Countries such as India have the Universal Immunisation Programme that aims to provide recommended vaccines against tuberculosis, polio, and other diseases including diphtheria, tetanus, and whooping cough for all Indian children. The country regularly conducts vaccination drives, which is expected to positively impact the growth of the market. These initiatives are expected to drive the growth of the market in the forecast period.

The inadequate access to vaccines in under-developed countries is expected to limit the growth of the DTP vaccines global market. According to the World Health Organization's global estimates, around 19.4 million infants did not have access to DTP vaccines and around 60% of these children live in under-developed and developing countries. Countries such as the Central African Republic, Chad, Equatorial Guinea, Guinea, Samoa, Somalia, South Sudan, Syrian Arab Republic, and Ukraine have less than 50% coverage of DTP vaccination. Lack of access to vaccines in under-developed countries is expected to hamper market growth.

Companies in the DTP vaccines market are increasingly investing in manufacturing DTP combination vaccines, which reduces multiple vaccination shots for immunization against infectious diseases. DTP combination vaccines such as tetravalent (DTP-HepB), pentavalent (DTP-HepB-Hib), and hexavalent vaccine (DTP-Hib-HepB-IPV) are available to provide the same protection as individual vaccine shots given separately.

In May 2020, Merck acquired Thermis, a company focused on vaccines and immuno-modulation therapies for infectious diseases, for an undisclosed amount. Thermis is involved in the discovery, development, and production of vaccines with a sophisticated and versatile technology platform. Merck is expected to leverage the vaccine technology enhanced by Thermis and the company will become a fully-owned subsidiary of Merck after the completion of this deal.

The regions covered in the DTP vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the DTP vaccines market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The DTP vaccines market research report is one of a series of new reports from The Business Research Company that provides DTP vaccines market statistics, including DTP vaccines industry global market size, regional shares, competitors with a DTP vaccines market share, detailed DTP vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the DTP vaccines industry. This DTP vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Product Code: r2057

1. Executive Summary

2. DTP Vaccines Market Characteristics

3. DTP Vaccines Market Trends And Strategies

4. DTP Vaccines Market - Macro Economic Scenario

4.1 COVID-19 Impact On DTP Vaccines Market

4.2 Ukraine-Russia War Impact On DTP Vaccines Market

4.3 Impact Of High Inflation On DTP Vaccines Market

5. DTP Vaccines Market Size And Growth

5.1. Global DTP Vaccines Historic Market, 2017-2022, $ Billion
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints On The Market
5.2. Global DTP Vaccines Forecast Market, 2022-2027F, 2032F, $ Billion
- 5.2.1. Drivers Of The Market
- 5.2.2. Restraints On the Market

6. DTP Vaccines Market Segmentation

6.1. Global DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
DTaP
TD
Tdap
6.2. Global DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Diphtheria
Pertussis
Tetanus.
6.3. Global DTP Vaccines Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals
Clinics
Vaccination Centers

7. DTP Vaccines Market Regional And Country Analysis

7.1. Global DTP Vaccines Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global DTP Vaccines Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific DTP Vaccines Market

8.1. Asia-Pacific DTP Vaccines Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China DTP Vaccines Market

9.1. China DTP Vaccines Market Overview
9.2. China DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India DTP Vaccines Market

10.1. India DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan DTP Vaccines Market

11.1. Japan DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia DTP Vaccines Market

12.1. Australia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia DTP Vaccines Market

13.1. Indonesia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea DTP Vaccines Market

14.1. South Korea DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe DTP Vaccines Market

15.1. Western Europe DTP Vaccines Market Overview
15.2. Western Europe DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK DTP Vaccines Market

16.1. UK DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany DTP Vaccines Market

17.1. Germany DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France DTP Vaccines Market

18.1. France DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe DTP Vaccines Market

19.1. Eastern Europe DTP Vaccines Market Overview
19.2. Eastern Europe DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia DTP Vaccines Market

20.1. Russia DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America DTP Vaccines Market

21.1. North America DTP Vaccines Market Overview
21.2. North America DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA DTP Vaccines Market

22.1. USA DTP Vaccines Market Overview
22.2. USA DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America DTP Vaccines Market

23.1. South America DTP Vaccines Market Overview
23.2. South America DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil DTP Vaccines Market

24.1. Brazil DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East DTP Vaccines Market

25.1. Middle East DTP Vaccines Market Overview
25.2. Middle East DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa DTP Vaccines Market

26.1. Africa DTP Vaccines Market Overview
26.2. Africa DTP Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa DTP Vaccines Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. DTP Vaccines Market Competitive Landscape And Company Profiles

27.1. DTP Vaccines Market Competitive Landscape
27.2. DTP Vaccines Market Company Profiles
- 27.2.1. Merck & Co
  - 27.2.1.1. Overview
  - 27.2.1.2. Products and Services
  - 27.2.1.3. Strategy
  - 27.2.1.4. Financial Performance
- 27.2.2. Sanofi
  - 27.2.2.1. Overview
  - 27.2.2.2. Products and Services
  - 27.2.2.3. Strategy
  - 27.2.2.4. Financial Performance
- 27.2.3. GSK
  - 27.2.3.1. Overview
  - 27.2.3.2. Products and Services
  - 27.2.3.3. Strategy
  - 27.2.3.4. Financial Performance
- 27.2.4. Lanzhou Institute of Biological Products
  - 27.2.4.1. Overview
  - 27.2.4.2. Products and Services
  - 27.2.4.3. Strategy
  - 27.2.4.4. Financial Performance
- 27.2.5. Novartis AG
  - 27.2.5.1. Overview
  - 27.2.5.2. Products and Services
  - 27.2.5.3. Strategy
  - 27.2.5.4. Financial Performance

28. DTP Vaccines Pipeline Analysis

29. Key Mergers And Acquisitions In The DTP Vaccines Market

30. DTP Vaccines Market Future Outlook and Potential Analysis

31. Appendix

31.1. Abbreviations
31.2. Currencies
31.3. Historic And Forecast Inflation Rates
31.4. Research Inquiries
31.5. The Business Research Company
31.6. Copyright And Disclaimer